Recent Finacing
Recent Raise
AIS Biotech develops GlycoFlu, a nasal antiviral of synthetic oligosaccharides that mimic cell-surface sugars to trap influenza before cell entry, and is building a bioproduction platform for complex sugars.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
